Fixed drug eruption due to methaqualone
L. Slazinski and D. W. Knox
We report three cases of fixed drug eruption due to methaqualone. Eruptions
from methaqualone have been rarely reported since the drug's introduction
in 1963. Our discovery of these three cases during a two-year period
suggests that dermatologic reactions from methaqualone may be much more
common than has been appreciated. This may be related to the reluctance of
the patient to admit to the use or abuse of methaqualone, and physicians'
lack of recognition of the widespread abuse of this drug and its possible
cutaneous complications.
